AUSTEDO XR
Live / Registered — Registered (as of 11 Jun 2024)
What this means for you
Registered since 11 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97261591
- Registration number
- 7414520
- Mark type
- Stylized text
- Filed
- 10 Feb 2022
- Published for opposition
- 19 Dec 2023
- Registered
- 11 Jun 2024
- Attorney of record
- Laurence Rickles
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of central nervous system diseases, namely, neurodegeneration, psychiatric conditions, pain, movement disorders
Owner
- AUSPEX PHARMACEUTICALS LLC, PARSIPPANY, NJ, US
- Auspex Pharmaceuticals, Inc., Parsippany, NJ, US
- Auspex Pharmaceuticals, Inc., Parsippany, NJ, US
- Auspex Pharmaceuticals, Inc., Parsippany, NJ, US
Prosecution history
- 11 Apr 2025 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 11 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 May 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 09 May 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Apr 2024 — ASSIGNED TO EXAMINER
- 05 Apr 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 14 Mar 2024 — USE AMENDMENT FILED
- 04 Apr 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 14 Mar 2024 — TEAS STATEMENT OF USE RECEIVED
- 13 Feb 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 19 Dec 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 19 Dec 2023 — PUBLISHED FOR OPPOSITION
- 29 Nov 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 17 Nov 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER